Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7875920 | 0.74 | EGLN1 (0.35) | GRIA2EGLN1 | |
| SCHEMBL27445281 | 0.72 | — | — | |
| SCHEMBL23829881 | 0.69 | — | — | |
| SCHEMBL4903107 | 0.61 | GRIA2 (0.43) | GRIA2 | |
| SCHEMBL4903114 | 0.61 | GRIA2 (0.43) | GRIA2 | |
| SCHEMBL4696355 | 0.61 | AGTR2 (0.32) | — | |
| Water SCHEMBL27874120 | 0.60 | GRIA2 (0.42) | GRIA2 | |
| SCHEMBL26096428 | 0.60 | — | — | |
| SCHEMBL8630981 | 0.60 | GRIA2 (0.34) | GRIA2EGLN1 | |
| SCHEMBL29017586 | 0.59 | EGLN1 (0.42) | GRIA2EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106029057-B | Oral formulations of pyrrolidine derivatives | 奥布赛瓦股份公司 | 2019-09-03 | — | — | CN | disclosed |
| CN-109928905-A | As oxytocins/pitressin V1a receptor antagonist pyrrolidin derivatives | 奥布赛瓦股份公司 | 2019-06-25 | — | — | CN | disclosed |
| CN-109748836-A | As oxytocins/pitressin V1a receptor antagonist pyrrolidin derivatives | 奥布赛瓦股份公司 | 2019-05-14 | — | — | CN | disclosed |
| CN-107674011-A | Pyrrolidin derivatives as oxytocins/pitressin V1a receptor antagonists | 奥布赛瓦股份公司 | 2018-02-09 | — | — | CN | disclosed |
| CN-106795110-A | Crystalline (3Z, 5S) -5- (hydroxymethyl) -1- [ (2 '-methyl-1, 1' -biphenyl-4-yl) carbonyl ] pyrrolidin-3-one O-methyloxime useful in methods of treating disorders associated with OT-R activity | 奥布赛瓦股份公司 | 2017-05-31 | — | — | CN | disclosed |